chartexchange

NVSEF
NOVARTIS AG BASEL AKT
stockOTC

EODNov 18, 2026
156.50USD-1.850%(-2.95)689

NVSEF Financials

In Q3 FY 2026 (ended ), NOVARTIS AG BASEL AKT (NVSEF) reported revenue of $14.52B, net income of $1.2B, and assets of $117.15B (filed ).

Loading financial statements…